The mission of the Chicago Biomedical Consortium (CBC) is to stimulate collaboration among scientists at Northwestern University, The University of Chicago, the University of Illinois at Chicago and others to accelerate discovery that will transform biomedical research and improve the health of humankind.
The CBC gratefully acknowledges support from the Searle Funds at The Chicago Community Trust.

June 21, 2017
CBC Newsletter, Vol. 21
Search for the CBC Associate Director for Translation Activities; Inviting New Catalyst Proposals; Announcing CBC Annual Symposium 2017

June 21, 2017
Search for the CBC Associate Director for Translation Activities
The CBC has opened a search for the CBC Associate Director for Translation Activities (ADTA), who will be responsible for the day-to-day management of new Phase 2 programs. Applications will be accepted through September 1, 2017.
▸ Read more
▸ Download the Position Description and Requirements (PDF)
▸ Apply

May 31, 2017
CBC Invites New Catalyst Applications

As the CBC moves into Phase 2, the Catalyst Award program will continue to support basic biomedical research by multi-institutional teams. NEW in Phase 2: projects with translational potential will also be considered. The eligibility requirements and application instructions are included in the revised Catalyst RFA (rev. May 30, 2017) and must be followed. The Fall 2017 Catalyst application round will open at 8AM on Monday, August 14, 2017 and will close at 5PM on Friday, August 18, 2017.
▸ Catalyst RFA (rev. May 30, 2017)

▸ More Announcements


June 20, 2017
“in the news”
6 largest gifts from individuals to healthcare organizations in 2017
According to the Becker’s Healthcare Report, Searle Funds gift to the CBC placed #3 nationwide among gifts and pledges from individuals to hospitals or healthcare organizations to date in 2017.
▸ Read more

June 14, 2017
Top 10 U.S. Biopharma Clusters
According to the Genetic Engineering & Biotechnology News (GEN), Chicagoland placed #10 among top 10 US Biopharma Clusters in 2017. The CBC and Jim Audia are featured.
▸ Read more

May 25, 2017
James E. (Jim) Audia, PhD to become Executive Director of CBC as Katie Stallcup Retires
Jim Audia, currently Chief Scientific Officer of Constellation Pharmaceuticals in Cambridge, Massachusetts, will become Executive Director of the CBC effective August 1, 2017. Dr. Audia succeeds Dr. Kathryn C. (Katie) Stallcup, who will retire in September.
▸ Read more
▸ Press Release

▸ More News

Featured Events

15th Annual CBC Symposium
“Small Molecule Discovery”

DATE: Friday, November 17, 2017

July 13, 2017
UIC Biological Sciences
NSF-sponsored “Finding Your Inner Modeler” workshop
Register by June 15!

July 14, 2017
UIC Mass Spectrometry
Chicago Mass Spec Day

September 28, 2017
NU International Institute for Nanotechnology (INN)
2017 IIN Symposium

▸ More Events